Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma
Overview
Oncology
Pharmacology
Affiliations
The role of cancer stem cells in esophageal squamous cell carcinoma (ESCC) remains unclear. The mRNA stemness index (mRNAsi) of 179 ESCC patients (GSE53625) was calculated using a machine learning algorithm based on their mRNA expression. Stemness-related genes were identified by weighted correlation network analysis (WGCNA) and LASSO regression, whose associations with mutation status, immune cell infiltrations, and potential compounds were also analyzed. The role of these genes in proliferation and their expressions was assessed in ESCC cell lines and 112 samples from our center. The ESCC samples had significantly higher mRNAsi than the normal tissues. Patients with high mRNAsi exhibited higher worse OS. Seven stemness-related genes were identified by WGCNA and LASSO regression, based on which a risk-predicted score model was constructed. Among them, CST1, CILP, PITX2, F2RL2, and RIOX1 were favorable for OS, which were adverse for DPP4 and ZFHX4 in the GSE53625 dataset. However, RIOX1 was unfavorable for OS in patients from our center. In vitro assays showed that CST1, CILP, PITX2, F2RL2, and RIOX1 were pro-proliferated, which were opposite for DDP4 and ZFHX4. In addition, SMARCA4, NOTCH3, DNAH5, and KALRN were more mutated in the low-score group. The low-score group had significantly more memory B cells, monocytes, activated NK cells, and Tregs and less macrophages M2, resting mast cells, and resting dendritic cells. Seven stemness-related genes are significantly related to the prognosis, gene mutations, and immune cell infiltration of ESCC. Some potential anticancer compounds may be favorable for OS.
Identification of a novel immune infiltration-related gene signature, , for coronary artery disease.
Ye W, Shen B, Tang Q, Fang C, Wang L, Xie L PeerJ. 2024; 12:e18135.
PMID: 39346078 PMC: 11438437. DOI: 10.7717/peerj.18135.
Jin X, Fu C, Qi J, Chen C Clin Exp Med. 2024; 24(1):127.
PMID: 38869635 PMC: 11176101. DOI: 10.1007/s10238-024-01387-z.
Zheng X, Liu W, Zhu Y, Kong W, Su X, Huang L Cancers (Basel). 2023; 15(17).
PMID: 37686677 PMC: 10487246. DOI: 10.3390/cancers15174399.
Li C, Zhou W, Zhu J, Shen Q, Wang G, Chen L Biomed Res Int. 2023; 2022:7413535.
PMID: 36588538 PMC: 9803573. DOI: 10.1155/2022/7413535.